Department of Molecular Biology and Genetics, Faculty of Science, Mugla Sitki Kocman University, Mugla, Turkey.
Department of Molecular Biology-Genetics and Biotechnology, Faculty of Science and Letters, Istanbul Technical University, Istanbul, Turkey.
Mol Cell Biochem. 2020 Oct;473(1-2):133-141. doi: 10.1007/s11010-020-03813-8. Epub 2020 Jun 29.
Abnormal activity of ERK/MAPK and PI3K/AKT pathways is one of the most important factors for the development of many cancer types including neuroblastoma cancer. Apart from these two pathways, some cell cycle regulators such as Speedy/RINGO also contribute to neuroblastoma development. There is data reinforcing the possible communication of the components of ERK/MAPK and PI3K/AKT pathways in carcinogenic process. In addition to this, there are studies about the direct/indirect interaction of Speedy/RINGO with these pathways in different cell types other than neuroblastoma. However, there is not any study available showing the interaction of Speedy/RINGO with both pathways in neuroblastoma cells. Therefore, the aim of this study is to determine the possible effect of Speedy/RINGO on PI3K/AKT and ERK/MAPK pathways in SH-SY5Y neuroblastoma cells. For this aim, Speedy/RINGO was silenced by siRNA technique to analyze the effects of direct inhibition of Speedy/RINGO on these pathways. Results showed that Speedy/RINGO silencing caused a significant decrease in MEK1/2 expression and AKT phosphorylation. Afterward, MEK1/2 was inhibited using a specific inhibitor U0126. Data reveal a corresponding decrease in the Speedy/RINGO expression and AKT phosphorylation indicating a reciprocal interaction between ERK/MAPK and Speedy/RINGO. In addition, MTS analysis showed that both ERK/MAPK inhibition and Speedy/RINGO silencing significantly reduced the viability of SH-SY5Y cells. This study provides information about a possible interaction of Speedy/RINGO with PI3K/AKT and ERK/MAPK pathways in SH-SY5Y cells for the first time. It will not only help to better understand the cancer-prone interactions of these pathways but also enable us to identify the appropriate molecular targets for developing efficient treatment strategies.
ERK/MAPK 和 PI3K/AKT 通路的异常活性是包括神经母细胞瘤在内的许多癌症类型发展的最重要因素之一。除了这两条通路外,一些细胞周期调节剂,如 Speedy/RINGO,也有助于神经母细胞瘤的发展。有数据支持 ERK/MAPK 和 PI3K/AKT 通路的成分在致癌过程中可能存在通讯。除此之外,还有研究表明 Speedy/RINGO 在不同类型的细胞中与这些通路存在直接/间接相互作用,而不仅仅是神经母细胞瘤。然而,目前尚无研究表明 Speedy/RINGO 在神经母细胞瘤细胞中与这两条通路相互作用。因此,本研究旨在确定 Speedy/RINGO 对 SH-SY5Y 神经母细胞瘤细胞中 PI3K/AKT 和 ERK/MAPK 通路的可能影响。为此,通过 siRNA 技术沉默 Speedy/RINGO,分析直接抑制 Speedy/RINGO 对这些通路的影响。结果表明,Speedy/RINGO 沉默导致 MEK1/2 表达和 AKT 磷酸化显著减少。随后,使用特异性抑制剂 U0126 抑制 MEK1/2。数据显示 Speedy/RINGO 表达和 AKT 磷酸化相应减少,表明 ERK/MAPK 和 Speedy/RINGO 之间存在相互作用。此外,MTS 分析表明,ERK/MAPK 抑制和 Speedy/RINGO 沉默均显著降低了 SH-SY5Y 细胞的活力。本研究首次提供了 Speedy/RINGO 与 SH-SY5Y 细胞中 PI3K/AKT 和 ERK/MAPK 通路相互作用的信息。这不仅有助于更好地理解这些通路的癌症易发性相互作用,还使我们能够确定开发有效治疗策略的适当分子靶标。